Levitra (PD-Rx Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Levitra drug offered from PD-Rx Pharmaceuticals, Inc.. This Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: PD-Rx Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: vardenafil hydrochloride
SUBSTANCE NAME: VARDENAFIL HYDROCHLORIDE TRIHYDRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2003-08-25
END MARKETING DATE: 0000-00-00


Levitra HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLevitra from PD-Rx Pharmaceuticals, Inc.
LABELER NAME: PD-Rx Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 20(mg/1)
START MARKETING DATE: 2003-08-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55289-193_4665b8b8-6bcd-4f98-e054-00144ff8d46c
PRODUCT NDC: 55289-193
APPLICATION NUMBER: NDA021400

Other VARDENAFIL HYDROCHLORIDE TRIHYDRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Bryant Ranch PrepackLevitra
PD-Rx Pharmaceuticals, Inc.Levitra